Downregulation of serum long noncoding RNA GAS5 may contribute to insulin resistance in PCOS patients
Downregulation of serum long noncoding RNA GAS5 may contribute to insulin resistance in PCOS patients
复制标题
血清长非编码RNA GAS5的下调可能导致PCOS患者的胰岛素抵抗
DOI:
10.1080/09513590.2018.1459548
复制
发表时间:
2018-01-01
影响因子:
2
通讯作者:
Zhang, Qingxue
中科院分区:
文献类型:
--
作者:
Lin, Haiyan;Xing, Weijie;Zhang, Qingxue
Abstract Polycystic ovary syndrome (PCOS) is a common endocrine disease that affects reproductive-aged women and mostly characterized by insulin resistance (IR). The underlying mechanism remains unknown. Long noncoding RNAs (lncRNAs) have been demonstrated to be involved in various levels of biological regulation process of cell development, metabolism, and differentiation. This study aims to investigate the relationship between IR and differential expression of lncRNA Growth-arrest specific transcript 5 (GAS5) in patients’ serum with and without PCOS. A total of 76 cases of serum was collected from non-PCOS and PCOS patients with and without IR to measure interleukin-18 (IL-18) and GAS5 expression, which were correlated with IR status. The IL-18 concentration in serums was significantly increased in PCOS patients with IR. GAS5 expression was decreased in serums in PCOS patients with IR. Result of correlation analysis shows that there is a negative association between GAS5 expression and homeostasis model of assessment for insulin resistance (HOMA-IR). GAS5 was yielded the ROC curve (AUC). Our study implied that elevated IL-18 expression and downregulation of GAS5 in serums might contribute to IR in PCOS patients.